Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor
Authors:
- J A Moreno-RomeroJMJ A Moreno-Romero
- S SeguraSSS Segura
- J M MascaróJ M Mascaró
- S E CowperSCS E Cowper
- M JuliàMJM Julià
- E PochEPE Poch
- A BoteyABA Botey
- C HerreroCHC Herrero
- 1 October 2007
- journal article
- case report
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 157 (4) , 783-787
Abstract
Nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing dermopathy is a rare fibrotic condition that presents in patients with a history of renal disease. The aetiology is unknown, but it has recently been proposed that gadolinium, a paramagnetic contrast agent, may be a trigger of this disease. We report three patients with NSF with a history of use of gadolinium in magnetic resonance angiography a few weeks before the onset of symptoms. In the future, gadolinium should probably be avoided as much as possible in renal insufficiency patients until its role in the development of NSF is clarified.Keywords
This publication has 17 references indexed in Scilit:
- Description of 12 Cases of Nephrogenic Fibrosing Dermopathy and Review of the LiteratureSeminars in Arthritis and Rheumatism, 2006
- Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?Nephrology Dialysis Transplantation, 2006
- Involvement of skeletal muscle in dialysis‐associated systemic fibrosis (nephrogenic fibrosing dermopathy)Muscle & Nerve, 2004
- Dialysis‐associated systemic fibrosis (nephrogenic fibrosing dermopathy): Study of inflammatory cells and transforming growth factor β1 expression in affected skinArthritis & Rheumatism, 2004
- Circulating fibrocytes: collagen-secreting cells of the peripheral bloodThe International Journal of Biochemistry & Cell Biology, 2004
- Nephrogenic fibrosing dermopathy: A rare entity in patients awaiting liver transplantationLiver Transplantation, 2004
- Nephrogenic Fibrosing Dermopathy With Systemic InvolvementArchives of Dermatology, 2003
- Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease)Journal of the American Academy of Dermatology, 2003
- SAFETY OF GADOLINIUM CONTRAST AGENT IN HEMODIALYSIS PATIENTSActa Radiologica, 2001
- Scleromyxoedema-like cutaneous diseases in renal-dialysis patientsThe Lancet, 2000